HB0502 amends Tennessee Code to mandate coverage for Kleefstra syndrome under TennCare.
HB0502 amends Tennessee Code to require the TennCare bureau to provide coverage and benefits for the diagnosis and treatment of Kleefstra syndrome, a rare genetic disorder. This includes genetic testing, therapy, medications, and other interventions. The bureau may apply for a federal waiver to implement these changes. The act takes effect July 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.